Skip to main content
Francisco Vega-Vazquez, MD, Pathology, Houston, TX

FranciscoVega-VazquezMDPhD

Pathology • Houston, TX

Hematopathology, Anatomic Pathology, Clinical Pathology

Profesor of Pathology, lymphoma section head. MD Anderson Cancer Center

Join to view full profile

Dr. Vega-Vazquez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Vega-Vazquez's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    MD Anderson Cancer Center
    Houston, TX 77030
    Phone+1 713-563-1294

Summary

  • I received my MD degree from the Universidad Complutense of Madrid (Spain) and my PhD in Cellular Biology by the Universidad de Navarra (Spain). I completed my residency-training program in Anatomic Pathology in the Clinica Universitaria de Navarra, Pamplona (Spain), and repeated an Anatomic Pathology residency in the United States at Baylor College of Medicine (Houston, TX). I worked as a Surgical Pathologist in the Department of Pathology of the Hospital de Orense (Galicia, Spain) from January 1998 to November 1999. I completed a fellowship in Hematopathology at M.D. Anderson Cancer Center (MDACC; Houston) in 2005. I am board certified in Anatomic Pathology, and in the subspecialty of Hematopathology, by the American Board of Pathology. I have been Associate Professor with the award of tenure and Chief of the Lymphoma Section at the Department of Hematopathology at MDACC until August 2013. I moved to the University of Miami (UM)/Sylvester Comprehensive Cancer Center to be the Director of the Division of Hematopathology in September 2013. Since then, I have done diagnostic signout in hematopathology and lead a research laboratory investigating signaling pathways that can be useful for targeted therapy in lymphoma.

    My patient care activities center around the diagnosis of specimens obtained from patients being evaluated for leukemia, lymphoma and/or plasma cell myeloma. I interpret bone marrow core biopsy and aspirate specimens; lymph node and tissue biopsies; immunophenotypic analyses, including immunohistochemistry and flow cytometry; and peripheral blood smears. I act as a consultant to the surgical pathology services and to other members of the Division of Hematopathology as well as colleagues from other institutions and clinical groups.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Hematopathology, 2005 - 2006
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Pathology-Anatomic and Clinical, 2003 - 2005
  • University of Navarra
    University of NavarraPh.D., Cell Biology, 1997
  • Complutense University of Madrid
    Complutense University of MadridClass of 1992

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2006 - 2025
  • FL State Medical License
    FL State Medical License 2013 - 2021
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Hematopathology

Awards, Honors, & Recognition

  • Janice Davis Singletary Award for Clinical Fellowship in Lymphoma MD Anderson Cancer Center, 2006
  • Award for Best Platform Presentation Galician Society of Gastroenterology, 1999
  • Scholarship Government of Navarra, Pamplona, Spain, 1996
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?  
    Campuzano-Zuluaga G, Deutsch Y, Salzberg M, Gomez A, Vargas F, Elias R, Kwon D, Goodman M, Ikpatt OF, Chapman JR, Watts J, Vega F, Swords R, Am J Hematol, 1/1/2016
  • Unusual immunophenotypic variant of large B-cell lymphoma associated with HHV-8 and EBV in an HIV positive patient  
    Ruiz-Cordero, R, Lewis J, Blieden C, Campuzano-Zuluaga G, Hernandez J, Lossos IS, Ikpatt F, Chapman JR, Vega F, Hum Path: Case Reports, 1/1/2015
  • Synaptophysin is frequently expressed in megakaryocytes: a novel immunohistochemical finding of unknown significance  
    Ruiz-Cordero R, Chapman J, Vega F, Rev LatinoAmer Patol Clin, 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Atlas of Tumor Pathology of the AFIP (Armed Forces Institute of Pathology) 
    Chapter: Tumors of the Lymph Node and Spleen Lymphoma 
    Medeiros, O'Malley, Caraway, Vega, Elenitoba-Johnson, and LimAmerican Registry of Pathology, Washington, DCEdition 4th,2017
  • Microenvironment abnormalities and cytokine network deregulation in lymphoma genesis and progression. 
    Page 35 - 50Blieden C, Agarwal NK, Vega FFuture Science Group, London, United Kingdom2015
  • Familial Cancer Syndromes. 
    Chapter: Diffuse large B cell lymphoma, II 
    Page 8 - 13Vega FEditors: V. Nose.Amirsys publishing2014
  • Join now to see all

Abstracts/Posters

  • Role of SMO in the activation of PI3k/AKT signaling in DLBCL.
    Haghefi A, Agarwal NK Kunkalla K, Kim CH, Tjendra Y, Landgraf R, Vega F, USCAP, San Antonio, TX, 1/1/2017
  • Mutational Frequency in Hispanic and Non-Hispanic Patients with Acute Myeloid Leukemia (AML): Updated Analysis of 227 Patients.
    Bradley TJ, Monge J, Talati C, Algaze SD, Vaupel CA, Chapman JR, Vega F, Hall J, Lancet JE, Padron E, Swords R, Watts JM, ASH, Atlanta, GA, 1/1/2017
  • Smoothened Stabilizes and Protects TRAF6 from Proteosomal Degradation: A Novel Non-Canonical Role of Smoothened with Implications in Lymphoma Biology.
    Qu C, Vaghefi A, Kunkalla K, Chapman JR, Liu Y, Blonska M, Alderuccio JP, Bernal-Mizrachi L, Lossos IS, Landgraf R, Vega F, ASH, Atlanta, GA, 1/1/2017
  • Join now to see all

Lectures

  • Genetic Analysis of Plasmablastic Lymphomas in HIV (+) Patients Reveals Novel Driver Regulators of the Noncanonical NF-Κb Pathway 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study Reflects the Demographics and Subtypes of Patients Diagnosed with Non-Hodgkin Lymphoma in the United States 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  •  
    University of Miami/Sylvester Comprehensive Cancer Center, Miami, FL - 1/1/2017
  • Join now to see all

Other

  • CD-ROM INTERPAT Interactive Teaching of Anatomic Pathology by Computer 
    Pardo-Mindan FJ, Sola I, Idoate M, de Alva E, Lozano MD, Panizo A, Vega F, Diaz L, Fernandez J
    Pamplona, Navarra, Spain - 1/1/1999

Dr. Francisco Vega-Vazquez, Dr. Francisco Vega-Vazquez, MD, Dr. F Vega-Vazquez